Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells

References

Baliga, B.C. and Kumar, S. (2002). Role of BCL-2 family of proteins in malignancy. Hematol. Oncol.20, 63–74.10.1002/hon.685Search in Google Scholar

Barry, M.A., Behnke, C.A., and Eastman, A. (1990). Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol.40, 2353–2362.10.1016/0006-2952(90)90733-2Search in Google Scholar

Beran, M., Estey, E., O'Brien, S., Cortes, J., Koller, C.A., Giles, F.J., Kornblau, S., Andreeff, M., Vey, N., Pierce, S.R., et al. (1999). Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia. J. Clin. Oncol.17, 2819–2830.10.1200/JCO.1999.17.9.2819Search in Google Scholar

Cheng, E.H.Y., Levine, B., Boise, L.H., Thompson, C.B., and Hardwick, J.M. (1996). Bax-independent inhibition of apoptosis by Bcl-XL. Nature379, 554–556.10.1038/379554a0Search in Google Scholar

Chomczynski, P. and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem.162, 156–159.10.1016/0003-2697(87)90021-2Search in Google Scholar

de Silva, C.P., de Oliveira, C.R., and de Conceicao, P.L. (1996). Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes. Biochem. Pharmacol.51, 1331–1340.10.1016/0006-2952(96)00041-XSearch in Google Scholar

Farber, S., Toch, R., Sears, E., and Pinkel, D. (1956). Advances in chemotherapy of cancer in man. In: Advances in Cancer Research, H.A. Greenstein, ed. (New York, USA: Academic Press), pp. 2–73.10.1016/S0065-230X(08)60721-6Search in Google Scholar

Floros, V.K., Thomadaki, H., Katsaros, N., Talieri, M., and Scorilas, A. (2004). mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2 family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biol. Chem.385, 1099–1103.10.1515/BC.2004.143Search in Google Scholar PubMed

Floros, V.K., Thomadaki, H., Lallas, G., Katsaros, N., Talieri, M., and Scorilas, A. (2003). Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells. Differential expression of BCL2 and novel apoptosis-related gene BCL2L12. Ann. NY Acad. Sci.1010, 153–158.10.1196/annals.1299.025Search in Google Scholar PubMed

Friesen, C., Herr, I., Krammer, P.H., and Debatin, K.-M. (1996). Involvement of the CD95 APO-1/Fas receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med.2, 574–577.10.1038/nm0596-574Search in Google Scholar PubMed

Gazzanelli, G., Luchetti, F., Burattini, S., Mannello, F., Falcieri E., and Papa, S. (2000). Matrix metalloproteinases expression in HL-60 promyelocytic leukemia cells during apoptosis. Apoptosis5, 165–172.10.1023/A:1009688831531Search in Google Scholar

Genestier, L., Paillot, R., Quemecuer, L., Izeradjene, K., and Revillard, J. (2000). Mechanisms of action of methotrexate. Immunopharmacology4, 247–257.10.1016/S0162-3109(00)00189-2Search in Google Scholar

Graham, P. and Stevenson, F. (2005). Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology114, 441–449.Search in Google Scholar

Harada, K., Ishibashi, S., Miyashita, T., Osuga, J., Yagyu, H., Ohashi, K., Yazaki, Y., and Yamada, N. (2002). Bcl-2 protein inhibits oxysterol-induced apoptosis through suppressing CPP32-mediated pathway. FEBS Lett.411, 63–66.Search in Google Scholar

Kalomenidis, I., Orphanidou, D., Papamichalis, G., Vassilakopoulos, T., Scorilas, A., Rasidakis, A., Papastamatiou, H., Jordanoglou, J., and Roussos, C. (2001). Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics. Lung179, 265–278.10.1007/s004080010067Search in Google Scholar

Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., and Green, D.R. (1998). DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell1, 543–551.10.1016/S1097-2765(00)80054-4Search in Google Scholar

Kaufmann, S. (1989). Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin and other cytotoxic anticancer drugs: a cautionary note. Cancer Res.49, 5870–5878.Search in Google Scholar

Kratzmeier, M., Albig, W., Hanecke, K., and Doenecke, D. (2000). Rapid dephosphorylation of H1 histones after apoptosis induction. J. Biol. Chem.275, 30478–30486.10.1074/jbc.M003956200Search in Google Scholar PubMed

Mathioudaki, K., Scorilas, A., Papadokostopoulou, A., Xynopoulos, D., Arnogianaki, N., Agnanti, N., and Talieri, M. (2004). Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer. Biol. Chem.385, 779–783.10.1515/BC.2004.101Search in Google Scholar PubMed

Mirowski, M., Rozalski, M., Krajewska, U., Balcerczak, E., Mlynarski, W., and Wierzbicki, R. (2003). Induction of caspase 3 and modulation of some apoptotic genes in human acute promyelocytic leukemia HL-60 cells by carboplatin with amifostine. Pol. J. Pharmacol.55, 227–234.Search in Google Scholar

Muller, M., Strand, S., Hug, H., Heinemann, E.M., Walczak, H., Hofmann, W.J., Stremmel, W., Krammer, P.H., and Galle, P.R., (1997). Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor ligand system and involves activation of wild-type p53. J. Clin. Invest.99, 403–413.10.1172/JCI119174Search in Google Scholar PubMed PubMed Central

Muller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S.L., Galle, P.R., Stremmel, W., Oren, M., and Krammer, P.H. (1998). p53 activates the CD95. J. Exp. Med.188, 2033–2045.Search in Google Scholar

Reed, J.C. (1997). Double identity for proteins of the Bcl-2-family. Nature387, 773–776.10.1038/42867Search in Google Scholar PubMed

Revelos, K., Petraki, C., Gregorakis, A., Scorilas, A., Papanastasiou, P., and Koutsilieris, M. (2005). Immunohistochemical expression of Bcl2 is an independent predictor of time-to-biochemical failure in patients with clinically localized prostate cancer following radical prostatectomy. Anticancer Res.25, 3123–3133.Search in Google Scholar

Rowinsky, E.K., Kaufmann, S.H., Baker, S.D., Miller, C.B., Sartorius, S.E., Bowling, M.K., Chen, T.L., Donehower, R.C., and Gore, S.D. (1996). A phase I and pharmacological study of topotecan infused over 30 minutes for five days in patients with refractory acute leukemia. Clin. Cancer Res.2, 1921–1930.Search in Google Scholar

Schliephacke, T., Meinl, A., Kratzmeier, M., Doenecke D., and Albig, W. (2004). The telomeric region is excluded from nucleosomal fragmentation during apoptosis, but the bulk nuclear chromatin is randomly degraded. Cell Death Differ.11, 693–703.10.1038/sj.cdd.4401414Search in Google Scholar PubMed

Scorilas, A., Kyriakopoulou, L., Yousef, G.M., Ashworth, L., Kwamie, A., and Diamandis, E.P. (2001). Molecular cloning, physical mapping and expression analysis of a novel gene, BCL2L12, encoding for a proline-rich protein with a highly conserved BH2 domain of the BCL2 family. Genomics72, 217–221.10.1006/geno.2000.6455Search in Google Scholar PubMed

Simonian, P.L., Grillot, D.A.M., Merino, R., and Nunez, G. (1996). Bax can antagonize Bcl-XL during etoposide- and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL. J. Biol. Chem.271, 22764–22772.10.1074/jbc.271.37.22764Search in Google Scholar PubMed

Talieri, M., Diamandis, E.P., Katsaros, N., Gourgiotis, D., Karida, I., and Scorilas, A. (2003). Expression of BCL2L12, a new member of apoptosis-related proteins, in breast tumors. Thromb. Haemost.89, 1081–1088.10.1055/s-0037-1613411Search in Google Scholar

Thomadaki, H. and Scorilas, A. (2006). BCL2 family of apoptosis-related genes: functions and clinical implications in cancer. Crit. Rev. Clin. Lab. Sci.43, 1–67.Search in Google Scholar

Thomadaki, H., Tsiapalis, C.M., and Scorilas, A. (2005). Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction. Biol. Chem.386, 471–480.10.1515/BC.2005.056Search in Google Scholar PubMed

Thomadaki, H., Talieri, M., and Scorilas, A. (2006). Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer. Cancer Lett., in press.Search in Google Scholar